VALGIMIGLI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 2.924
AS - Asia 1.456
EU - Europa 659
SA - Sud America 275
AF - Africa 25
OC - Oceania 2
Totale 5.341
Nazione #
US - Stati Uniti d'America 2.868
SG - Singapore 633
CN - Cina 410
BR - Brasile 223
DE - Germania 145
HK - Hong Kong 131
UA - Ucraina 131
VN - Vietnam 126
GB - Regno Unito 98
TR - Turchia 60
IT - Italia 55
RU - Federazione Russa 50
SE - Svezia 43
FI - Finlandia 42
MX - Messico 30
CA - Canada 21
PL - Polonia 21
IN - India 20
AR - Argentina 19
FR - Francia 17
ID - Indonesia 17
ZA - Sudafrica 15
JP - Giappone 14
BD - Bangladesh 12
BE - Belgio 11
EC - Ecuador 10
ES - Italia 10
CO - Colombia 9
IQ - Iraq 8
AL - Albania 6
IE - Irlanda 6
NL - Olanda 6
LT - Lituania 5
PK - Pakistan 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
AT - Austria 3
CL - Cile 3
JO - Giordania 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
MA - Marocco 2
OM - Oman 2
PY - Paraguay 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
AU - Australia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 5.341
Città #
Singapore 324
Ashburn 317
Woodbridge 290
Fairfield 286
Beijing 171
Santa Clara 167
Ann Arbor 164
Chandler 153
Houston 138
Jacksonville 133
Hong Kong 131
Seattle 118
Wilmington 107
New York 72
Cambridge 65
Los Angeles 57
Ho Chi Minh City 51
Princeton 43
Dallas 39
Izmir 37
Nanjing 37
San Diego 29
Bremen 25
Hanoi 24
Munich 24
Mexico City 22
São Paulo 22
Boardman 21
Buffalo 21
Shanghai 21
Warsaw 19
Milan 18
Falkenstein 16
Jakarta 16
Chicago 14
Shenyang 14
Jiaxing 13
Phoenix 13
Redwood City 13
Tokyo 13
Brooklyn 12
Helsinki 12
Brussels 11
Dearborn 11
Denver 11
London 11
Nanchang 11
Tianjin 11
Bologna 10
Changsha 10
Orem 10
Jinan 9
Moscow 9
Boston 8
Hefei 8
Rio de Janeiro 8
Toronto 8
Washington 8
Ferrara 7
Leawood 7
Montreal 7
Nuremberg 7
San Mateo 7
Stockholm 7
Auburn Hills 6
Baghdad 6
Johannesburg 6
Manchester 6
Norwalk 6
Poplar 6
Ankara 5
Atlanta 5
Charlotte 5
Chennai 5
Curitiba 5
Da Nang 5
Dong Ket 5
Falls Church 5
Mountain View 5
Ninh Bình 5
San Francisco 5
San Jose 5
Zhengzhou 5
Addison 4
Augusta 4
Belo Horizonte 4
Dhaka 4
Dublin 4
Hangzhou 4
Mumbai 4
Philadelphia 4
Quito 4
Turku 4
Agudos 3
Amman 3
Amsterdam 3
Biên Hòa 3
Bragança Paulista 3
Campo Grande 3
Haiphong 3
Totale 3.640
Nome #
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 231
Poor response to clopidogrel: current and future options for its management 225
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 213
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 208
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 202
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 199
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 174
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 174
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 174
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 171
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 161
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 157
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 155
Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial 147
Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry 146
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates 143
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 140
Poor responsiveness to clopidogrel. Drug-specific or class-effect? 139
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 138
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial 137
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy 136
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 133
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 126
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial 125
Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention. Insights Into the STRATEGY Study 125
CD34+ cells mobilization in myocardial infarction: a link with heart failure? 116
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Insights From the EXAMINATION Trial 116
Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients 114
High-dose bolus tirofiban and sirolimus-eluting stent versus abciximab and bare metal stent in acute myocardial infarction (STRATEGY) study 110
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 104
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 91
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 87
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI 87
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 81
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 78
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies—meta-analysis of prospective studies 77
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 62
null 61
null 61
Stable angina pectoris 49
Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction 47
Totale 5.420
Categoria #
all - tutte 29.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021269 0 0 0 0 0 41 19 51 7 51 70 30
2021/2022453 16 51 54 20 23 14 35 27 14 33 49 117
2022/2023362 46 5 19 49 68 58 9 29 47 8 16 8
2023/2024275 25 26 11 8 17 81 10 13 5 8 5 66
2024/2025951 10 26 87 28 126 120 20 19 181 100 133 101
2025/20261.547 284 148 253 336 373 153 0 0 0 0 0 0
Totale 5.420